Antimycobacterial constituents from Juniperus procera, Ferula communis and Plumbago zeylanica and their in vitro synergistic activity with isonicotinic acid hydrazide

Phytotherapy Research

Volumn 18, Issue 11, 2004, Pages 934-937

  Mossa, Jaber S ^a   El Feraly, Farouk S ^a   Muhammad, Ilias ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Antimycobacterial constituents; Atypical mycobacteria; Isonicotinic acid hydrazide; Mycobacterium tuberculosis H37Rv; Synergism

Indexed keywords

7BETA HYDROXYABIETA 8,13 DIEN 11,12 DIONE; FERULA COMMUNIS EXTRACT; FERULENOL; ISONIAZID; JUNIPERUS PROCERA EXTRACT; PLANT EXTRACT; PLUMBAGIN; PLUMBAGO ZEYLANICA EXTRACT; TOTAROL; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; ATYPICAL MYCOBACTERIUM; CHEMICAL STRUCTURE; DRUG ISOLATION; DRUG POTENCY; DRUG POTENTIATION; FERULA COMMUNIS; IN VITRO STUDY; JUNIPERUS; JUNIPERUS PROCERA; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM INTRACELLULARE; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS H37RV; MYCOBACTERIUM XENOPEI; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PLANT; PLUMBAGO ZEYLANICA; SAUDI ARABIA;

ANTITUBERCULAR AGENTS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FERULA; HUMANS; ISONIAZID; JUNIPERUS; MEDICINE, TRADITIONAL; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PHYTOTHERAPY; PLANT BARK; PLANT EXTRACTS; PLANT LEAVES; PLANTS, MEDICINAL; PLUMBAGINACEAE; SAUDI ARABIA;

ATYPICAL MYCOBACTERIA; CORYNEBACTERINEAE; FERULA COMMUNIS; JUNIPERUS PROCERA; MYCOBACTERIUM; MYCOBACTERIUM INTRACELLULARE; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; PLUMBAGO ZEYLANICA;

EID: 11144241343     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1420     Document Type: Article

References (26)

1. Al-Yahya MA, Muhammad I, Mirza HH, El-Feraly FS. 1998. Antibacterial constituents from the rhizomes of Ferula communis. Phytother Res 12: 335-339.
2. Barbaro DJ, Orcutt VL, Coldiron BM. 1989. Mycobacterium avium - Mycobacterium intracellulare infection limited to the skin and lymph nodes in patients with AIDS. J Infect Dis 11: 625-628.
3. Clark AM, El-Feraly FS, Li WS. 1981. Antimicrobial activity of phenolic constituents of Magnolia grandiflora L. J Pharm Sci 70: 951-952.
4. Collenette S. 1985. An Illustrated Guide to the Flowers of Saudi Arabia. Scorpion: London, 221.
5. Constantine GH, Karchesy JJ, Franzblau SG, LaFleur LE. 2001. (+)-Totarol from Chamaecyparis nootkatensis and activity against Mycobacterium tuberculosis. Fitoterapia 72: 572-574.
6. Dawson DJ, Blacklock JM, Hayward AJ, Walsh MJ. 1981. Differential identification of mycobacteria in smears of sputum. Tubercle 62: 257-262.
7. Guthertz LS, Damsker B, Bottone EJ, Ford EG, Midura TF, Janda JM. 1989. Mycobacterium avium and Mycobacterium intracellulare infections in patients with and without AIDS. J Infect Dis 160: 1037-1041.
8. Himejima M, Kubo I. 1992. Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial. J Nat Prod 55: 620-625.
9. Kubo I, Himejima M, Tsujimoto K, Muroi H. 1992a. Antibacterial activity of crinitol and its potentiation. J Nat Prod 55: 780-785.
10. Kubo I, Muroi H, Himejima M. 1992b. Antibacterial activity of totarol and its potentiation. J Nat Prod 55: 1436-1440.
11. Kubo I, Taniguchi M. 1988. Polygadiol, an antifungal potentiator. J Nat Prod 51: 22-29.
12. Mitscher LA, Leu R-P, Bathala MS, Wu W-N, Beal JL. 1972. Antimicrobial plants from higher plants. I. Introduction, rationale and methodology. Lloydia 35: 157-166.
13. Mossa JS, Muhammad I, El-Feraly FS. 1992. 3β-Hydroxyabieta-8,11,13- tiene-1-one and other constituents from Juniperus excelsa leaves. Phytochemistry 31: 2789-2792.
14. Muhammad I, Mossa JS, El-Feraly FS. 1992. Antibacterial diterpenes from the leaves and seeds of Juniperus excelsa. Phytother Res 6: 261-264.
15. Muhammad I, Mossa JS, Al-Yahya MA, Ramadan AF, El-Feraly FS. 1995. Further antibacterial diterpenes from the bark and leaves of Juniperus procera Hochst. Ex Endl. Phytother Res 9: 584-588.
16. Muhammad I, Mossa JS, El-Feraly FS. 1996. Additional antibacterial diterpenes from the bark of Juniperus procera. Phytother Res 10: 604-607.
17. Norden CW, Wentzel H, Keleti E 1979. Comparison of techniques for measurement of in vitro antibiotic synergism. J Infect Dis 140: 629-633.
18. Renneberg, J. 1993. Definitions of antibacterial interactions in animal infection models. J. Antimicrob Chemother 31: 167-175.
19. San Feliciano A, Gordaliza M, Salinero MA, Meguel del Corral JM. 1993. Abietane acids: sources, biological activities and therapeutic uses. Planta Med 59: 485-490.
20. Schreiber J, Burkhardt U, Rusch-Gerder S, et al. 2001. Non-tubercular mycobacterial infection of the lung due to Mycobacterium smegmatis. Pneumologie 55: 238-243.
21. Swenson JM, Thornsberry C, Silcox VA. 1982. Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution. Antimicrob. Agents Chemother 22: 186-192.
22. Toussirot E, Chevrolet A, Wendung D. 1998. Tenosynovitis due to Mycobacterium avium- intracellulare and Mycobacterium chelonei: Report of two cases with review of literature. Rheumatology 17: 151-156.
23. Vichkanova SA, Izosimova SB, Adgina VV, Shipulina LD. 1979. Search for antimicrobial drugs among quinones of plant origin. Rastit Resur 15: 167-177.
24. th, Naukova Dumka: Kiev; 90-94.
25. Yue JM, Lin ZW, Wang D, Feng Y, Sun H. 1994. Plumbasides A-C, three napthoquinone derivatives from Ceratostigma minus. Phytochemistry 35: 1023-1025.
26. Wolinsky E. 1992. Mycobacterial diseases other than tuberculosis. Clin Infect Dis 15: 1-10.